Enzolytics Stock Buy Hold or Sell Recommendation
| ENZC Stock | USD 0 0.0001 11.11% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Enzolytics is 'Strong Sell'. Macroaxis provides Enzolytics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ENZC positions.
Check out Enzolytics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Enzolytics and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Enzolytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Enzolytics |
Execute Enzolytics Buy or Sell Advice
The Enzolytics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Enzolytics. Macroaxis does not own or have any residual interests in Enzolytics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Enzolytics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Enzolytics Trading Alerts and Improvement Suggestions
| Enzolytics generated a negative expected return over the last 90 days | |
| Enzolytics has high historical volatility and very poor performance | |
| Enzolytics has some characteristics of a very speculative penny stock | |
| Enzolytics has high likelihood to experience some financial distress in the next 2 years | |
| Enzolytics currently holds 233.12 K in liabilities. Enzolytics has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Enzolytics until it has trouble settling it off, either with new capital or with free cash flow. So, Enzolytics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Enzolytics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Enzolytics to invest in growth at high rates of return. When we think about Enzolytics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 190 K. Net Loss for the year was (57.28 K) with profit before overhead, payroll, taxes, and interest of 52.81 K. |
Enzolytics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Enzolytics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Enzolytics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Enzolytics Returns Distribution Density
The distribution of Enzolytics' historical returns is an attempt to chart the uncertainty of Enzolytics' future price movements. The chart of the probability distribution of Enzolytics daily returns describes the distribution of returns around its average expected value. We use Enzolytics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Enzolytics returns is essential to provide solid investment advice for Enzolytics.
| Mean Return | -1.33 | Value At Risk | -14.29 | Potential Upside | 11.11 | Standard Deviation | 7.30 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Enzolytics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Enzolytics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Enzolytics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Enzolytics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Enzolytics pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.39 | |
β | Beta against Dow Jones | 0.42 | |
σ | Overall volatility | 7.29 | |
Ir | Information ratio | -0.2 |
Enzolytics Volatility Alert
Enzolytics is displaying above-average volatility over the selected time horizon. Enzolytics is a penny stock. Even though Enzolytics may be a good instrument to invest, many penny pink sheets are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Enzolytics or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Enzolytics instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Enzolytics Fundamentals Vs Peers
Comparing Enzolytics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Enzolytics' direct or indirect competition across all of the common fundamentals between Enzolytics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Enzolytics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Enzolytics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Enzolytics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Enzolytics to competition |
| Fundamentals | Enzolytics | Peer Average |
| Return On Asset | -7.05 | -0.14 |
| Operating Margin | (19.24) % | (5.51) % |
| Current Valuation | 71.57 M | 16.62 B |
| Shares Outstanding | 2.44 B | 571.82 M |
| Price To Sales | 2,083 X | 11.42 X |
| Revenue | 190 K | 9.43 B |
| Gross Profit | 52.81 K | 27.38 B |
| EBITDA | (886.77 K) | 3.9 B |
| Net Income | (57.28 K) | 570.98 M |
| Cash And Equivalents | 5.76 K | 2.7 B |
| Total Debt | 233.12 K | 5.32 B |
| Current Ratio | 0.01 X | 2.16 X |
| Book Value Per Share | (0.63) X | 1.93 K |
| Cash Flow From Operations | 4.89 M | 971.22 M |
| Earnings Per Share | (4.76) X | 3.12 X |
| Number Of Employees | 7 | 18.84 K |
| Beta | -0.0481 | -0.15 |
| Market Capitalization | 125.65 M | 19.03 B |
| Total Asset | 3.31 M | 29.47 B |
| Net Asset | 3.31 M |
Enzolytics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Enzolytics . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Enzolytics Buy or Sell Advice
When is the right time to buy or sell Enzolytics? Buying financial instruments such as Enzolytics Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Enzolytics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Furniture Thematic Idea Now
Furniture
Companies producing and selling home and office furniture. The Furniture theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Furniture Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Enzolytics Pink Sheet
Enzolytics financial ratios help investors to determine whether Enzolytics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Enzolytics with respect to the benefits of owning Enzolytics security.